News

Targeted Oncology56m
Seiter Explores Time of Initiation and Alternate Dosing of Ruxolitinib in Myelofibrosis
During a live event, Karen Seiter, MD, discussed the role of the JAK/STAT pathway in myeloproliferative neoplasms and the use ...